OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level
Angelo D’Alessandro, Tiffany Thomas, Monika Dzieciątkowska, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 11, pp. 4417-4427
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients
Tiffany Thomas, Davide Stefanoni, Monika Dzieciątkowska, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 11, pp. 4455-4469
Open Access | Times Cited: 254

Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution
Edoardo Caronna, Alejandro Ballvé, Arnau Llauradó, et al.
Cephalalgia (2020) Vol. 40, Iss. 13, pp. 1410-1421
Open Access | Times Cited: 201

Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
E. Barberis, Virginia Vita Vanella, Marco Falasca, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 174

A time-resolved proteomic and prognostic map of COVID-19
Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke, et al.
Cell Systems (2021) Vol. 12, Iss. 8, pp. 780-794.e7
Open Access | Times Cited: 163

Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
François‐Xavier Danlos, Claudia Grajeda‐Iglesias, Sylvère Durand, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 145

Advances and Utility of the Human Plasma Proteome
Eric W. Deutsch, Gilbert S. Omenn, Zhi Sun, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 12, pp. 5241-5263
Open Access | Times Cited: 138

High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
Philipp E. Geyer, Florian M. Arend, Sophia Doll, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 8
Open Access | Times Cited: 118

Specialized interferon action in COVID-19
Matthew D. Galbraith, Kohl T. Kinning, Kelly D. Sullivan, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 11
Open Access | Times Cited: 82

COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
Michele Costanzo, Marianna Caterino, Roberta Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2414-2414
Open Access | Times Cited: 67

Complement in Secondary Thrombotic Microangiopathy
Lílian Monteiro Pereira Palma, Meera Sridharan, Sanjeev Sethi
Kidney International Reports (2020) Vol. 6, Iss. 1, pp. 11-23
Open Access | Times Cited: 87

A serum proteome signature to predict mortality in severe COVID-19 patients
Franziska Völlmy, Henk van den Toorn, Riccardo Zenezini Chiozzi, et al.
Life Science Alliance (2021) Vol. 4, Iss. 9, pp. e202101099-e202101099
Open Access | Times Cited: 79

Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
David H. Jiang, Darius J. Roy, Brett Gu, et al.
JACC Basic to Translational Science (2021) Vol. 6, Iss. 9-10, pp. 796-811
Open Access | Times Cited: 68

Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential
Kruthi Suvarna, Deeptarup Biswas, Medha Gayathri J. Pai, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 67

EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
Mukesh Chourasia, Purushotham Reddy Koppula, Aruna Battu, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1200-1200
Open Access | Times Cited: 63

Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications
Jonathan P. Meizoso, Hunter B. Moore, Ernest E. Moore
Journal of the American College of Surgeons (2021) Vol. 232, Iss. 6, pp. 995-1003
Open Access | Times Cited: 56

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19
Małgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, et al.
Blood Advances (2021) Vol. 6, Iss. 3, pp. 1074-1087
Open Access | Times Cited: 55

A proteomic survival predictor for COVID-19 patients in intensive care
Vadim Demichev, Pinkus Tober‐Lau, Tatiana Nazarenko, et al.
PLOS Digital Health (2022) Vol. 1, Iss. 1, pp. e0000007-e0000007
Open Access | Times Cited: 47

Complement activation in COVID-19 and targeted therapeutic options: A scoping review
Endry H. T. Lim, Rombout B. E. van Amstel, Vieve Victoria de Boer, et al.
Blood Reviews (2022) Vol. 57, pp. 100995-100995
Open Access | Times Cited: 46

Hemolytic anemia in COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Annals of Hematology (2022) Vol. 101, Iss. 9, pp. 1887-1895
Open Access | Times Cited: 43

Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Edoardo Caronna, Thomas C. van den Hoek, Hayrünnisa Bolay, et al.
Cephalalgia (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 29

Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review
Marianne Riou, F Coste, Alain Meyer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4941-4941
Open Access | Times Cited: 7

Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes
Arthur Viodé, Kinga K. Smolen, Patrick van Zalm, et al.
Science Advances (2024) Vol. 10, Iss. 21
Open Access | Times Cited: 7

Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19
Selin Gencer, Michael Lacy, Dorothee Atzler, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 12, pp. 1629-1641
Open Access | Times Cited: 59

Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
Edoardo Caronna, Patricia Pozo‐Rosich
Current Pain and Headache Reports (2021) Vol. 25, Iss. 11
Open Access | Times Cited: 52

Page 1 - Next Page

Scroll to top